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Introduction
Mechanical ventilation generally exerts negative hemo-
dynamic eﬀ  ects in patients with normal cardiac function 
mainly because of the reduction in venous return induced 
by positive intrathoracic pressure at each insuﬄ   ation [1]. 
By contrast, positive pressure ventilation exerts beneﬁ  cial 
eﬀ  ects in patients with cardiogenic pulmonary edema such 
that it is routinely used as a therapy in this category of 
patients [2, 3]. Conversely, cardiac consequences of 
spontaneous breathing may be responsible for weaning 
failure in patients with left heart disease, even though the 
mechanical ventilation was required for respiratory failure 
of non-cardiac origin. Since its ﬁ  rst description more than 
twenty years ago [4], cardiogenic pulmonary edema has 
been recognized as a frequent cause of weaning failure in 
patients with underlying left cardiac dysfunction.
In this chapter, we ﬁ  rst brieﬂ  y summarize the mecha-
nisms by which pulmonary edema can develop during 
weaning. We then emphasize how weaning failure of cardiac 
origin can be detected at the bedside since signiﬁ  cant 
progress has recently been made in this ﬁ  eld. Finally, we 
describe the therapeutic options currently available.
Mechanisms contributing to the development of 
weaning-induced pulmonary edema
Th  e mechanisms that contribute to development of 
cardiogenic pulmonary edema during weaning have been 
extensively detailed in a previous review [5]. Th  ese 
mechanisms are complex and mainly include the 
inspiratory fall in intrathoracic pressure, the increase in 
work of breathing, and the catecholamine discharge that 
occur during abrupt transfer from mechanical ventilation 
to spontaneous breathing [5]. Inspiratory fall in intra-
thoracic pressure tends to increase the systemic venous 
return pressure gradient and the central blood volume 
[5], and to decrease the left ventricular (LV) ejection 
pressure gradient with a resulting increase in LV afterload 
[5]. A marked increase in work of breathing may increase 
cardiac work and myocardial oxygen demand [5]. Th  e 
increased adrenergic tone may also increase venous 
return, LV afterload, cardiac work, and myocardial 
oxygen demand and may thus potentially result in 
myocardial ischemia in predisposed patients [4, 6]. In 
patients with pre-existing right ventricular (RV) disease, 
an increase in weaning-induced RV afterload may occur 
because of hypoxemia or worsening of intrinsic positive 
end-expiratory pressure (PEEPi) [5]. In addition to the 
simultaneous increase in systemic venous return, the 
increased RV afterload may lead to a marked RV enlarge-
ment during weaning, thus impeding the diastolic ﬁ  lling 
of the left ventricle through a biventricular inter-
dependence mechanism [5]. In summary, elevation of the 
LV ﬁ lling pressure can occur during weaning because of 
an increase in LV preload and/or decrease in LV com-
pliance (myocardial ischemia, biventricular interdepen-
dence) and/or increase in LV afterload. However, in the 
absence of left heart disease, the rise in pulmonary artery 
occlusion pressure (PAOP) is limited [7, 8]. In contrast, 
marked increases in PAOP have been reported to occur 
during unsuccessful weaning in patients with left heart 
disease [4, 9–12], who can thus be suspected to have 
failed to wean because of the onset of cardiogenic pulmo-
nary edema.
Diagnosis of weaning-induced pulmonary edema
Clinical context
Th  e diagnosis of weaning-induced pulmonary edema 
should be suspected when intolerance to a spontaneous 
breathing trial (SBT) occurs and other causes of weaning 
failure have been discarded. Th   e suspicion is reinforced by 
the fact that the patient has a previous history of left heart 
disease. Patients with a combination of left heart disease 
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higher risk of weaning-induced pulmonary edema. In this 
situation, the increase in airway resistance ampliﬁ  es two 
mechanisms responsible for LV ﬁ  lling pressure elevation: 
1) the fall in intrathoracic pressure is exaggerated at 
inspiration leading to a marked increase in LV afterload 
during spontaneous breathing; and 2) the work of breath-
ing further augments leading to increased myocardial 
oxygen demand with inherent risks of myocardial ischemia 
in predisposed patients. In addition, the biventricular 
interdependence phenomenon can be marked in COPD 
patients with pre-existing RV dilation and thus can 
signiﬁ  cantly contribute to LV ﬁ  lling pressure elevation.
Th  e early onset of respiratory distress after starting a 
weaning trial is assumed to be suggestive of weaning-
induced pulmonary edema, although there is no clear 
evidence in the literature to support this assumption. In 
our experience, the combined increase in arterial 
pressure and heart rate during unsuccessful weaning is 
quite suggestive of weaning failure of cardiac origin [11, 
12], although false positive and false negatives can be 
encountered [11].
Right heart catheterization
Right heart catheterization can be helpful in the evaluation 
of acute dyspnea in patients with concomitant pulmonary 
and cardiac disease, since it allows measure  ment of PAOP, 
pulmonary artery pressure, right atrial pressure, and 
oxygen-derived variables [13]. In this regard, right heart 
catheterization was ﬁ   rst proposed to establish the 
diagnosis of weaning-induced pulmonary edema. A higher 
than normal value of PAOP measured during an 
unsuccessful SBT is highly suggestive of weaning-induced 
pulmonary edema [14]. Th   ere is no deﬁ  nite value of PAOP 
above which cardiogenic pulmo  nary edema develops, 
although 18  mmHg is recognized as a classical cut-oﬀ   
value [15]. Numerous studies have shown increases in 
PAOP during weaning in patients who failed to wean [4, 
9–12]. Lemaire and colleagues [4] reported an average 
increase in transmural PAOP from 8 to 25  mmHg in 
unsuccessful weaning trials in 15 patients with both COPD 
and left heart disease. Interestingly, after diuretic therapy, 
60% of these diﬃ     cult-to-wean patients could be suc 
cessfully weaned with no further increase in PAOP during 
weaning [4]. Th  is strongly suggests that the weaning-
induced elevation of PAOP played a major role in the 
diﬃ   culty to wean of these patients.
In all these studies, the increase in PAOP during 
unsuccessful weaning was not associated with a decrease 
in cardiac output [4, 10–12]. In fact, the weaning process 
is quite similar to an exercise test such that an increase in 
cardiac output is expected to occur in response to the 
increased work of breathing and to the stress created by 
the abrupt transfer of the patient from mechanical 
ventilation to spontaneous breathing [16]. Patients with 
impaired cardiac function may fail to suﬃ   ciently increase 
cardiac output and oxygen transport in response to 
increased oxygen requirements. Th   ese patients may thus 
experience not only an increase in PAOP but also a 
decrease in mixed venous blood saturation (SvO2) during 
weaning as reported in clinical studies [10–12]. Although 
the decrease in SvO2 is obviously not an indicator of 
cardiogenic pulmonary edema, it can identify weaning 
failure from cardiac origin as well as the elevation in 
PAOP can. As long as the central venous oxygen satura-
tion (ScvO2) reﬂ  ects  SvO2, simple central venous 
catheterization could thus be a tool to detect weaning 
failure from cardiac origin. Further studies are, however, 
needed to conﬁ  rm this hypothesis.
To summarize, right heart catheterization can be 
helpful for diagnosing weaning failure from cardiac 
origin since it may not only identify patients with 
elevated PAOP during weaning but also provide impor-
tant information about the mechanisms responsible for 
weaning-induced acute cardiac dysfunction. Neverthe-
less, pulmonary artery catheterization remains an 
invasive procedure [13]. Recent research studies have 
been undertaken to ﬁ  nd less invasive tools for identifying 
weaning failure from cardiac origin.
Transthoracic echocardiography
Echocardiography has become a routine tool for evaluat-
ing the cardiovascular status in critically ill patients. It is 
now possible to estimate LV ﬁ   lling pressures using 
Doppler transmitral ﬂ   ow and Doppler tissue imaging 
variables [17]. Doppler transmitral ﬂ  ow allows the early 
(E) and late (A) peak diastolic velocities to be measured, 
and tissue Doppler imaging of the mitral annulus allows 
the early (Ea) peak mitral annulus diastolic velocity to be 
measured. In a series of 39 diﬃ   cult-to-wean  patients, 
Lamia and colleagues [12] tested the hypothesis that E/A 
and E/Ea could be used to detect weaning-induced 
elevation deﬁ  ned by a PAOP ≥ 18 mmHg during a SBT. 
Th   e major ﬁ  nding of this study was that the combination 
of E/A > 0.95 and of E/Ea > 8.5 at the end of the SBT 
predicted a PAOP ≥ 18 mmHg with good sensitivity 
(82%) and speciﬁ  city (91%) while the cut-oﬀ   values of E/
A alone and of E/Ea alone had weak speciﬁ  city (68% and 
73%, respectively). Th  e study by Lamia and colleagues 
[12] thus provides evidence that a totally non-invasive 
method can identify patients with weaning-induced 
pulmonary edema. Moreover, as echocardiography is a 
valuable method to evaluate cardiac function at the 
bedside, it can also provide clinicians with important 
information about the main mechanisms responsible for 
cardiac dysfunction during weaning. However, echo-
cardio  graphy is an operator-dependent method that 
requires a long training period to ensure critical care 
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tools that can more simply detect weaning-induced 
pulmonary edema are, therefore, necessary.
Cardiac biomarkers
B-type natriuretic peptide (BNP) and N-terminal proBNP 
(NT-proBNP) are peptides synthesized by the ventricular 
myocytes in response to an increased myocardial stretch. 
Both systolic and diastolic dysfunction of the left 
ventricle can result in high circulating BNP and NT-
proBNP levels. In critically ill patients, such cardiac 
biomarkers are increasingly used as screening tools to 
rule out cardiac dysfunction [18, 19]. Two recent studies 
addressed the question of whether BNP or NT-proBNP 
could be used to identify patients who fail to wean for 
cardiac reasons [20, 21]. However, the results of these 
two studies are not straightforward. Mekontso-Dessap 
and colleagues showed that, before the ﬁ  rst  weaning 
attempt, the plasma BNP level was higher in patients 
with subsequent weaning failure [20]. Th   e area under the 
receiver operating characteristic (ROC) curve for plasma 
BNP to predict weaning failure was 0.89 ± 0.04 and a cut-
oﬀ   value of 275 pg/ml was associated with the highest 
diagnostic accuracy (86%). However, one may wonder 
whether it is really pertinent to predict results of a simple 
and safe test such as a SBT, rather than performing it. 
Indeed, simply observing how a patient breathes during 
an unsuccessful SBT can provide a large amount of 
information about the mechanisms responsible for the 
weaning failure. Th  erefore, in our opinion, there is no 
real need to measure the BNP level simply in order to 
avoid performance of a SBT. Moreover, the fact that 
plasma BNP concentration was higher before the SBT in 
patients who subsequently failed the SBT does not mean 
that cardiac dysfunction and cardiogenic pulmonary 
edema occurred during the SBT. High baseline plasma 
BNP concentration before the SBT may rather reﬂ  ect a 
more severe global condition in patients who did not 
tolerate the SBT. It should be stressed that the plasma 
BNP level can be elevated in cases of advanced age, 
sepsis, renal dysfunction, and pulmonary hypertension, 
even in the absence of left heart dysfunction [18]. In this 
context, systolic cardiac dysfunction assessed by echo-
cardiography did not diﬀ   er between patients who 
succeeded and patients who failed the weaning trial in 
the study by Mekontso-Dessap and colleagues [20]. 
Moreover, there was no diﬀ  erence in the BNP level before 
and at the end of the weaning trial in the two groups of 
patients. Overall the results reported by Mekontso-
Dessap and colleagues [20] underline the uncertainty of 
using plasma BNP levels to reliably identify patients who 
experience weaning failure of cardiac origin. Th   e study by 
Grasso and colleagues [21] evaluated the signiﬁ  cance of 
NT-proBNP in detecting weaning failure of cardiac 
origin in COPD patients. Th   e cardiac origin of weaning 
failure was determined by one cardiologist and one 
critical care physician blinded to the results of the 
NT-proBNP measurements [21]. Th  eir diagnosis was 
based on the review of echocardiograms, electro-
cardiograms (EKGs), and clinical, hemodynamic, gas 
exchange and respiratory variables obtained at baseline 
and at the end of the SBT. Interestingly, the elevation of 
NT-proBNP during a SBT but not the baseline 
NT-proBNP predicted weaning-induced cardiac dysfunc-
tion with an acceptable accuracy [21]. Because of the 
limited number of patients included in this study, 
conﬁ  rmation in a larger cohort of patients is needed.
Clearly, suspicion of acute cardiac dysfunction during 
weaning using a change in NT-proBNP levels should 
prompt further cardiac evaluation (e.g., echocardio-
graphy) aimed at conﬁ   rming the cardiac origin of 
weaning failure. In our opinion, the divergent results 
reported by Mekontso-Dessap and colleagues [20] and 
Grasso and colleagues [21] should urge caution in the use 
of natriuretic peptide values for diagnosing weaning-
induced pulmonary edema. It must be stressed that in 
neither of these two studies was pulmonary artery 
catheterization performed to evidence elevation of PAOP 
during weaning. Further studies are thus mandatory.
Detection of weaning-induced hemoconcentration
Weaning-induced pulmonary edema is assumed to be a 
hydrostatic pulmonary edema resulting from an 
increased LV ﬁ   lling pressure. Hydrostatic pulmonary 
edema is accompanied by transfer of a hypo-oncotic ﬂ  uid 
from the lumen of the pulmonary capillaries toward the 
interstitium [22]. When the amount of transferred ﬂ  uid is 
large enough, hydrostatic pulmonary edema may result 
in hemoconcentration that could be detected on the basis 
of changes in plasma protein or hemoglobin concen-
trations or hematocrit [22] (Figure 1). In a recent study, 
we hypothesized that an acute occurrence of hemo-
concentration during weaning could help to diagnose 
weaning-induced pulmonary edema [11]. We deﬁ  ned 
weaning-induced pulmonary edema as intolerance to 
spontaneous breathing and elevation of PAOP above 
18 mmHg at the end of a SBT. We inserted a pulmonary 
artery catheter in 46 patients who failed two consecutive 
SBTs although there was no obvious cause of weaning 
failure [11]. Twenty-four of these patients experienced 
weaning-induced pulmonary edema with an increase in 
the median value of PAOP from 13 mmHg (range: 7–
16 mmHg) to 26 mmHg (range: 18–50 mmHg) during 
the third SBT [11]. In these patients, the plasma protein 
concentration increased signiﬁ  cantly during the SBT. An 
increase in plasma protein concentration greater than 6% 
during the weaning trial enabled weaning-induced 
pulmonary edema to be detected with a sensitivity of 87% 
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very high positive likelihood ratio value (19.25) and a 
negative likelihood ratio value of 0.13 [11]. Th  e area 
under the ROC curve generated for changes in plasma 
protein concentration (0.93 ± 0.04) was signiﬁ  cantly 
higher than that generated for changes in SvO2 during 
the SBT (0.70 ± 0.08) [11]. Interestingly, in 13 patients 
who experienced weaning-induced pulmonary edema at 
the third SBT, the fourth weaning trial was again 
monitored with a pulmonary artery catheter after they 
had received diuretics and/or vasodilators [11]. None of 
these patients experienced recurrent weaning-induced 
pulmonary edema and the plasma protein concentration 
did not change during their fourth SBT [11]. Th  is  study 
strongly suggests that measuring acute changes in plasma 
protein concentration during a weaning trial represents a 
minimally invasive alternative to right heart catheteri-
zation for identifying patients that experience weaning-
induced pulmonary edema.
No study has compared the diﬀ  erent tools aimed at 
diagnosing the cardiac origin of weaning failure. In our 
opinion, measuring the change in plasma protein 
concentration during a SBT is the simplest tool for 
reliably screening patients for weaning-induced pulmo-
nary edema. Echocardiography can provide further 
conﬁ  rmation, and can also oﬀ  er useful information about 
the mechanisms responsible for the weaning failure.
Therapeutic options
Th  e treatment of weaning-induced pulmonary edema 
should obviously take into account the mechanism suspected 
to be mainly responsible for the weaning failure. It is thus 
important to ﬁ   rst carefully analyze the cardiovascular 
response to a SBT and then to monitor the chosen therapy 
using an invasive or non-invasive hemodynamic tool.
Diuretic therapy must be considered when excessive 
increased preload during weaning is suggested as the 
main mechanism responsible for weaning failure. In this 
context, in the study by Lemaire and colleagues [4], 9 of 
the 15 patients who initially failed to wean because of 
development of pulmonary edema successfully weaned after 
one week of treatment with furosemide, which resulted in 
ﬂ  uid losses equivalent to 5 litres. After treat  ment, PAOP was 
lower at the end of a SBT than it was before treatment was 
administered (9 ± 3 vs 25 ± 15 mmHg). Th  e attitude of 
empirically giving diuretics in every diﬃ   cult-to-wean 
patient has become more and more frequent. 
Nevertheless, it seems to us diﬃ   cult to recommend such 
an approach since extra-cardiac causes are responsible 
for weaning failure in at least 50% of this group of 
patients [11, 12] and since uncontrolled diuretic therapy 
can have potentially harmful eﬀ  ects.
In cases where excessive increased afterload is suspected 
as the main mechanism, administration of vaso  dilators 
may be chosen instead of (or in addition to) diuretics. In 
our experience, the onset of a marked increase in systolic 
arterial pressure during a SBT represents a reasonable 
indication for vasodilator adminis  tration. Nitrates may be 
a good therapeutic choice since this treatment can 
decrease both LV afterload and central blood volume 
(cardiac preload eﬀ   ect). In addition, because of its 
coronary vasodilating eﬀ  ects, it can be even more helpful 
when myocardial ischemia is one of the mechanisms 
responsible for the weaning failure.
Use of β1-agonist agents, such as dobutamine, is not 
logical in this context since weaning-induced pulmonary 
edema can hardly be caused by a reduction in cardiac 
contractility (see above). Moreover, unsuccessful weaning 
is associated with a huge increase in endogenous 
catecholamine discharge and administration of β1-agonist 
Figure 1. Consequences of fl  uid transfer during hydrostatic pulmonary oedema. (a) As weaning-induced pulmonary edema is of a 
hydrostatic nature, its development is characterized by transfer of a hypo-oncotic fl  uid from the pulmonary capillary lumen toward the interstitial 
compartment and then the alveoli. Molecules like proteins cannot fl  ow across the lung barrier owing to their high molecular weight. (b) After 
equilibrium is reached, weaning-induced pulmonary edema is thus characterized by a contraction of the vascular compartment and an 
augmentation in the plasma protein concentration.
lung
vascular compartment
protein molecules (a) (b)
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with its inherent risks of myocardial ischemia in 
predisposed patients. However, phosphodiesterase 
inhibitors, such as enoximone, have been reported to be 
eﬃ   cacious for treating the weaning-induced pulmonary 
edema that can develop after cardiac surgery [9]. It is 
likely that the vasodilating eﬀ  ect of these drugs could 
have signiﬁ  cantly contributed to their beneﬁ  cial impact. 
Finally, calcium channel blockers have been reported to 
facilitate successful weaning in the particular context of 
hypertrophic cardiomyopathy [23].
In terms of ventilatory modalities, there is no deﬁ  nite 
recommendation. After unsuccessful weaning of cardiac 
origin, reinstitution of mechanical ventilation is manda-
tory. Th  e practice of progressive decrements of pressure 
support levels while keeping 5 to 8 cmH2O of PEEP could 
be an interesting option since pressure support is assumed 
to increase LV afterload less than spontaneous breathing 
[24]. After extubation, non-invasive positive pressure venti-
lation using a face mask could be used. However, there is 
no deﬁ  nite recommendation about this practice [25].
Conclusion
Acute cardiac dysfunction and cardiogenic pulmonary 
edema may occur during weaning from mechanical 
ventila  tion, especially in patients with a history of left 
heart disease and COPD. Among the complex and 
intricate mechanisms, myocardial ischemia, excessive 
increased LV afterload, and increased cardiac preload 
play predominant contributing roles. Measuring the 
elevation in PAOP using right heart catheterization was 
ﬁ  rst proposed as a means of diagnosing weaning failure 
of cardiac origin. Less invasive tools, such as trans-
thoracic echocardiography or measurements of plasma 
protein concentration, have recently been proposed as 
valuable alternative diagnostic methods for weaning-
induced pulmonary edema. Th  ere is no codiﬁ  ed treat-
ment for weaning-induced pulmonary edema. Use of 
diuretics and/or nitrates should be considered after 
careful analysis of the main contributing mechanisms.
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